XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.4
LOSS PER SHARE AND STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Dec. 31, 2022
EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY  
Schedule of Reconciliation of Numerator And Denominator of Basic and Diluted Loss Per Share
A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts):
 
For the three months endedFor the nine months ended
December 31,December 31,
2022202120222021
Basic earnings (loss) per share:
Net loss from continuing operations$(30,520)$(15,375)$(88,174)$(4,441)
Earnings from discontinued operations, net of tax836 — 836 — 
Net loss$(29,684)$(15,375)$(87,338)$(4,441)
Basic weighted-average shares outstanding64,784 68,190 66,761 68,187 
Continuing operations$(0.47)$(0.23)$(1.32)$(0.07)
Discontinued operations0.01 — 0.01 — 
Basic loss per share$(0.46)$(0.23)$(1.31)$(0.07)
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding64,784 68,190 66,761 68,187 
Dilutive effect of common stock options and restricted stock as computed under the treasury stock method (1)— — — — 
Diluted weighted-average shares outstanding64,784 68,190 66,761 68,187 
Continuing operations$(0.47)$(0.23)$(1.32)$(0.07)
Discontinued operations0.01 — 0.01 — 
Diluted loss per share$(0.46)$(0.23)$(1.31)$(0.07)
Loss per share totals may not sum due to rounding.
(1) The number of common stock options and restricted stock units as computed under the treasury stock method that would have otherwise been dilutive but are excluded from the table above because their effect would have been anti-dilutive due to the net loss position of the Company was 0.5 million and 1.7 million in the three months ended December 31, 2022 and 2021, respectively, and 0.6 million and 1.4 million in the nine months ended December 31, 2022 and 2021, respectively.
Schedule of Anti-dilutive Options, Warrants and Restricted Stock Units Excluded from Computation of Loss Per Share
Restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because their effect would have been anti-dilutive (other than due to the net loss position of the Company) are shown below (shares in thousands):
 
For the three months endedFor the nine months ended
December 31,December 31,
2022202120222021
Number of shares underlying restricted stock units6,215 484 2,980 787